Fortfahren mit
Anmelden zur Ansicht der Organisations- und Vertragspreise.
Über diesen Artikel
Form:
lyophilized powder
Biological source:
Staphylococcus aureus
biological source
Staphylococcus aureus
form
lyophilized powder
extent of labeling
~2 mg per mL
matrix
Cross-linked 4% beaded agarose
matrix activation
cyanogen bromide
matrix attachment
amino
matrix spacer
1 atom
capacity
≥20 mg/mL (Human IgG)
storage temp.
2-8°C
Application
Protein A-agarose is used for affinity chromatography, antibody purification and characterization, and protein A, G and L resins. Protein A-agarose has been used to study the effects of protein A immunoadsorption in patients with chronic dilated cardiomyopathy as well as to study multiple sclerosis and gastric cancer.
Physical form
Lyophilisiertes Pulver stabilisiert mit Lactose
Preparation Note
Volumenzunahme: 1 g quillt auf ca. 4 mL.
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| biological source Staphylococcus aureus | biological source Staphylococcus aureus | biological source - | biological source Staphylococcus aureus |
| form lyophilized powder | form saline suspension | form essentially salt-free, lyophilized powder | form aqueous ethanol suspension |
| storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C |
| matrix Cross-linked 4% beaded agarose | matrix - | matrix - | matrix Sepharose 4B Fast Flow |
| matrix activation cyanogen bromide | matrix activation cyanogen bromide | matrix activation - | matrix activation cyanogen bromide |
| extent of labeling ~2 mg per mL | extent of labeling ~2 mg per mL | extent of labeling - | extent of labeling ~6 mg per mL |
Lagerklasse
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.



